hero-banner-image

TOGETHER, WE'VE GOT THIS.

耐心Can't Wait. Neither Can We.™

Learn More

Covance named 2020 Global CRO Company of the Year by Frost & Sullivan

RECOGNITION

Covance named 2020 Global CRO Company of the Year by Frost & Sullivan

As pharma and biotech sponsors increasingly rely on contract research organizations (CROs) for cost-effective and time-efficient drug development, Frost & Sullivan has analyzed which CROs are helping sponsors navigate clinical trials, meeting changing regulatory guidelines, expediting development and rapidly adopting new technologies. Congrats to our global team members for helping us make a difference for our sponsors – and patients around the world – to earn the honor of the 2020 Global CRO Company of the Year Award.

Read More
image of a smartphone

临床试验的转化方法

Labcorp Transforms the Clinical Trial Experience to Streamline its Drug Development Process

Company goes beyond decentralized clinical trials to deliver seamless tech-enabled, patient-centric enterprise solutions. Labcorp now offers a comprehensive and fully integrated patient, site, and customer experience for DCTs.

Learn More
Covance announces acquisition of snapIoT

Covance announces acquisition of snapIoT

Covance announces acquisition of snapIoT

Labcorp has announced that Covance has completed the transaction to acquire snapIoT, the fastest growing platform as a service provider of mobile-connected self-service platform solutions. This acquisition enables Covance to offer highly configurable and inter-operable patient centric solutions that enable remote participation in clinical trials, reduce patient burden while speeding implementation and improving data quality.

Read More

We’re in this together

COVID-19

Whether you are developing a COVID-19 assay, a vaccine to prevent patients from getting COVID-19, an antiviral or a treatment to mitigate the severe immunological response (cytokine storm) associated with COVID-19, we can partner with you to provide critical drug development and diagnostic services to address the global pandemic.

Read More

News

Covance宣布收购Globalcare临床试验，LLC

Labcorp has announced that Covance has completed the transaction to acquire GlobalCare, a globally recognized industry leader in patient-centric decentralized clinical trials (DCTs). The acquisition of GlobalCare will expand the Covance DCTs offering into global markets and help us meet your growing demand for patient-centric trial designs.

Read More

Covance Innovation

患者等不及了。既不是我们可以

The healthcare industry is always looking to the future... to discover a better treatment... to deliver a cure... to prevent disease…to improve quality of life. And it’s our mission to help speed that process. What matters is not “how it’s always been done,” but how it can be done now. Better. And Faster. Through new approaches explored, ideas perfected, and transformational thinking.

Read More

#COVANCEPOTENTIAL

It's not just a job. To us, it's personal.

Covance, the drug development business of Labcorp, is recognized as a leader in drug development because of our exceptional people. We embrace and celebrate the different strengths, experiences and perspectives of our 65,000+ enterprise team members across the globe. Our team is driven by an energizing purpose to improve health and improve lives. Here, you can play a role in bringing new scientific discoveries to life and make a difference in the lives of millions. Join us and discover your extraordinary potential.
Explore Careers

Covance by the Numbers

Annual Encounters 160M 耐心
Supports Clinical Trials in 100+ Countries
Collaborated on 100% Novel Oncology Drugs
Helped Develop 86% Rare & Orphan Drugs

Contributed in the development of all the current top 50 drugs on the market

Covance Insights

COVID-19: vaccine innovation and safety at pandemic speed
COVID-19: vaccine innovation and safety at pandemic speed
博客帖子
Covid-19的全球传播及其对人口健康和福祉的影响很大，因此举办了一个以前所未有的速度开发有效疫苗的种族。通常跨越几年的发展过程正在压缩成一年或更少。安全是该过程的重要组成部分，因此我们确定并讨论了疫苗开发中安全的几个关键因素和考虑因素。本文提供了我们见解的概要。
Read More
关闭小儿肿瘤药物发展的差距：监管景观与儿童竞争法
关闭小儿肿瘤药物发展的差距：监管景观与儿童竞争法
文章
目前的监管环境可以帮助支持儿科肿瘤发起的复杂努力，因为监管机构和立法行为有助于鼓励，激励甚至要求在其他适应症中进行儿科试验。本白皮书提供了小儿癌症治疗进展的简要历史，概述了监管变化如何影响儿科药物开发领域，并为申请当前规定提供指导，例如专注于小儿科肿瘤的儿童行为竞争。这种变化应该有助于提高肿瘤药物发展的包容性监管策略。
Read More
Medical Device and Diagnostic Solutions: Preclinical and Experimental Surgery
Medical Device and Diagnostic Solutions: Preclinical and Experimental Surgery
Craft the optimal preclinical strategy by collaborating with our medical device development specialists. Then access the preclinical resources necessary to make your initial development stage easier. Whether you are exploring a promising device concept, initiating a comprehensive testing plan or conducting a single study, Covance Medical Device and Diagnostic Solutions can help you prove out your device in its earliest stage of development.
Read More
Patient-Centric Field Reimbursement Quadruples Enrollment, Increases Stakeholder Satisfaction
Patient-Centric Field Reimbursement Quadruples Enrollment, Increases Stakeholder Satisfaction
文章
A top-5 pharmaceutical company partnered with Covance to provide field reimbursement management (FRM) services for their autoimmune infusion therapy program. Learn more about how Covance played a critical role in facilitating enrollment and stakeholder satisfaction.
Read More

Visit the Knowledge Libraryto learn more about our industry.

Stay up to date with the latest news from Covance

现在订阅

Learn More
Covance logo


Covance by Labcorp is a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries.

COVANCE is a registered trademark and the marketing name for Covance Inc. and its subsidiaries around the world.

导航
Scroll to top